Invention Application
WO2014071339A3 BREMELANOTIDE THERAPY FOR FEMALE SEXUAL DYSFUNCTION 审中-公开
女性性功能障碍的BREMELANOTIDE治疗

BREMELANOTIDE THERAPY FOR FEMALE SEXUAL DYSFUNCTION
Abstract:
Use of a subcutaneously administered dose of between about 1,0 mg and 175 mg of bremelanotide or a pharmaceutically acceptable salt of bremelanotide for the treatment of female sexual dysfunction in women while reducing or minimizing undesirable side effects.
Patent Agency Ranking
0/0